brivaracetam
brivaracetam is listed in the FDA National Drug Code directory with 50 NDC codes, marketed under brand names including brivaracetam, Brivaracetam, Briviact. Available dosage forms: solution, injection, tablet, film coated, injection, suspension, powder.
Drug Details
- Generic Name
- brivaracetam
- Brand Names
- brivaracetam, Brivaracetam, Briviact, BRIVARACETAM
- Application Number
- ANDA218494
- Sponsor
- Zhejiang Poly Pharm. Co., Ltd.
- NDC Codes
- 50
- Dosage Forms
- SOLUTION, INJECTION, TABLET, FILM COATED, INJECTION, SUSPENSION, POWDER
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- BRIVARACETAM
Indications and Usage
1 INDICATIONS AND USAGE BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )